6 October 2011 -- The BioIndustry Association (BIA) has today appointed Janis Clayton, Keith Martin, Diana Sternfeld and Ian Tomlinson to its Board of Directors at its Annual General Meeting. In addition, John Brown, Jeremy Haigh, Stephen Harris, Edward Hodgkin, Geoff Newman, Peter Nolan and Sam Williams have been re-appointed. The new Board members will serve from1 January 2012.
Tim Edwards, BIA Chairman, said:
“I would like to welcome those new Board members joining in January 2012 and thank those who are standing down at the end of the year. Our Board provides extremely valuable expertise to the BIA. Their sector experience plays a key role in determining how the BIA can best represent its members’ needs.”
For further information, please contact Robert Winder, Communications Manager, 020 7565 7193; mobile 07825 942 934. Notes to editors
Janis Clayton is General Manager and Vice President of Shire Human Genetic Therapies
Keith Martin is Chief Executive Officer of Apitope
Diana Sternfeld is a Partner at Rouse Legal
Ian Tomlinson is Senior Vice President, Head of Biopharmaceuticals R&D and Worldwide Business Development at GlaxoSmithKline
John Brown is Chairman of BTG
Jeremy Haigh is Vice President and International Chief Operating Officer, Research and Development at Amgen
Stephen Harris is Chief Executive Officer of Circassia Limited
Edward Hodgkin is Chief Executive Officer of Biotica
Geoff Newman is co-founder and Managing Director of Interea International
Peter Nolan is Executive Director and Senior Vice President, Commercial Development at Oxford BioMedica
Sam Williams is Chief Executive Officer of Modern Biosciences
BioIndustry Association
Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives. For further information, please go to www.bioindustry.org
The BIA events programme provides numerous opportunities for topical debate about emerging trends and key issues - plus excellent networking opportunities all year-round.
Up-Coming Events And Seminars:
Intellectual Property Hot Topics Seminar
Friday 21 October, London.
Health Research: Easier, Better, Faster - Showcasing UK translational research
Thursday 24 November, London.
BIA Gala Dinner 2012
Thursday 26 January, London.
Please note the BIA’s new contact details:
BioIndustry Association,
7th Floor, Southside,
105 Victoria Street,
London
SW1E 6QT
Telephone: +44 (0) 207 630 2180
Fax: +44 (0) 207 900 2443
